Marketing have to pass GMP.doc

 PAGE \* MERGEFORMAT 30 Marketing have to pass GMP The next three years, the pharmaceutical companies in life and death China’s per capita drug expenditure in a growing situation, pharmaceutical companies did not earn that pours. National Development and Reform Commission published the latest data show that in 2006 the accumulated loss-making enterprises of China’s Pharmaceutical Industry 1368, the industry face a loss of 22.62%, these enterprises amounted to a loss of 4.463 billion yuan, an increase of 27.37%. State Food and Drug Administration, concerned that the pharmaceutical industry is currently a daily average of two manufacturing companies and three distribution companies ‘die’. In other words, within three years 30% - 50% of the pharmaceutical companies will be mergers and restructuring, 60% of the brand would not exist, 80% of the pharmaceutical business enterprises will be closed down. At present, over 5000 transformation GMP manufacturing enterprises, GSP-certified circulation of nearly ten thousand companies had invested billions of reconstruction funds, the pharmaceutical industry a full range of overcapacity has come: ‘the capital of cement-based’ problem is serious, a large number of new plant remained idle and more than 40% of the oral preparation production line is stopped state, will be around 2008 is the industry’s GMP / GSP project five years of the loan deadline. The pharmaceutical industry since 2004 to face drug price cuts straight, drug classification management, prescription drugs limited sales, advertising regulation, the fight against commercial bribery medicine macro-control policies such as pressure, from the manufacturers point of view, the pharmaceutical industry an unprecedented grim situation and the marketing environment. Many people are thinking about the next step, how to do pharmaceutical marketing? We say that only GMP production is not enough, companies also have been marketing on the GMP mark! GMP production, but